- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05851040
Observe the Effect of Wheatgrass and Tulsi Formulation or Individuals Taken With Other Allopathic Drugs
May 5, 2023 updated by: Swalife Biotech
Observation of Wheatgrass and Tulsi Formulation or Its Effect With Allopathic Drugs
Antioxidant qualities have been attributed to wheatgrass and tulsi formulation.
Free radicals are unstable molecules created by the body during metabolism and exposure to environmental pollutants.
Antioxidants are chemicals that can help stop or reduce cell damage caused by these unstable molecules.
Oxidative stress, which is brought on by free radicals, has been connected to a number of health issues, including chronic inflammation, cardiovascular disease, cancer, and ageing.
Wheatgrass is a rich source of vitamins, minerals, amino acids, and chlorophyll, which have been shown to have antioxidant and anti-inflammatory effects.
Tulsi, also known as holy basil, is an herb that has been used in Ayurvedic medicine for centuries and has been found to have antioxidant, anti-inflammatory, and immunomodulatory properties.
Several studies have investigated the antioxidant properties of wheatgrass and tulsi formulation.
For instance, a study published in the Journal of Food Science and Technology in 2015 found that wheatgrass extract had significant antioxidant activity, as measured by its ability to scavenge free radicals and reduce lipid peroxidation in vitro.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
Similarly, a study published in the Journal of Ethnopharmacology in 2001 found that tulsi extract had significant antioxidant activity, as measured by its ability to scavenge free radicals and inhibit lipid peroxidation in vitro.
Moreover, a study published in the Journal of Medicinal Food in 2011 investigated the antioxidant and anti-inflammatory effects of a combination of wheatgrass and tulsi extracts in rats.
The study found that the combination of wheatgrass and tulsi extracts had significant antioxidant and anti-inflammatory effects, as measured by reductions in oxidative stress markers and pro-inflammatory cytokines.
Overall, the available evidence suggests that wheatgrass and tulsi formulations may have antioxidant properties, which could potentially help prevent or slow down oxidative stress-related health problems.
However, more research is needed to confirm these findings and determine the optimal dosage and duration of wheatgrass and tulsi formulation use for maximum antioxidant benefits.
There are several studies that suggest wheatgrass and tulsi formulations have antioxidant properties.
A study evaluated the immunomodulatory and antioxidant properties of a traditional formulation containing Tulsi, ginger, and wheatgrass.
Another study investigated the antioxidant potential of anthocyanin extracts from colored wheat flour and wheat-grass juice.
Additionally, a synergistic effect of conventional medicinal herbs against oxidative stress was observed in another study that included tulsi and wheatgrass.
While a study compared the chemical composition, sensory, phenolic, and antioxidant properties of juices from different wheatgrass and turfgrass species, it did not specifically investigate a formulation with tulsi.
Another study found that vitamin C is present in wheatgrass which is also an antioxidant.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pravin Badhe, PhD
- Phone Number: 91 7038248513
- Email: drpravinbadhe@swalifebiotech.com
Study Locations
-
-
Maharashtra
-
Pune, Maharashtra, India, 411041
- Sinhgad college of Pharmacy
-
Contact:
- Pravin Badhe, PhD
- Phone Number: 91 7038248513
- Email: drpravinbadhe@swalifebiotech.com
-
Principal Investigator:
- Pravin Badhe, PhD
-
Sub-Investigator:
- Ashwini Badhe, Master
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The population of age group 30 to 65 is targeted who have chronic disease and are taking wheat grass and tulsi formulation.
Description
Inclusion Criteria:
- Patients who are having a chronic disease and taking formulation wheat grass and tulsi.
- Patients who are taking wheatgrass and tulsi separately.
- Patients who are taking wheatgrass, tulsi and regular medicine. -
Exclusion Criteria:
- Patients below 30 years.
- Patients who are having a chronic disease but not using formulations of wheatgrass and tulsi.
- Patients who are not taking wheatgrass and tulsi separately.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
With Wheatgrass, tulsi formulation
People using Wheatgrass and Tulsi formulation or individual
|
Looking to find the role of wheatgrass and tulsi give separately or with allopathic drug
|
With Wheatgrass, tulsi formulation and allopathic drugs
People using Wheatgrass and Tulsi formulations or individuals with chronic disease medicine.
|
Looking to find the role of wheatgrass and tulsi give separately or with allopathic drug
|
Same age group not using any medication
|
Looking to find the role of wheatgrass and tulsi give separately or with allopathic drug
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of wheat grass and tulsi in combination on blood pressure
Time Frame: Every four week till 6 months
|
Blood Pressure measured in mmHg every four week.
|
Every four week till 6 months
|
Effect of wheat grass and tulsi in combination on blood sugar
Time Frame: Every four week till 6 months
|
Blood Sugar measured in mmol/L every four week
|
Every four week till 6 months
|
Effect of wheat grass and tulsi in combination on weight
Time Frame: Every four week till 6 months
|
Weight is measure in Kg every four week.
|
Every four week till 6 months
|
Effect of wheat grass and tulsi in combination on smoking
Time Frame: Every four week till 6 months
|
questionnaire assesment for "Smoking habits"
|
Every four week till 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of wheat grass and tulsi separately on blood pressure
Time Frame: Every four week till 6 months
|
Blood Pressure measured in mmHg every four week.
|
Every four week till 6 months
|
Effect of wheat grass and tulsi separately on blood sugar
Time Frame: Every four week till 6 months
|
Blood Sugar measured in mmol/L every four week.
|
Every four week till 6 months
|
Effect of wheat grass and tulsi separately on weight
Time Frame: Every four week till 6 months
|
Weight is measure in Kg every four week.
|
Every four week till 6 months
|
Effect of wheat grass and tulsi separately on smoking
Time Frame: Every four week till 6 months
|
questionnaire assesment for "Smoking habits"
|
Every four week till 6 months
|
Effect of wheat grass, tulsi and allopathic drug on blood pressure
Time Frame: Every four week till 6 months
|
Blood Pressure measured in mmHg every four week.
|
Every four week till 6 months
|
Effect of wheat grass, tulsi and allopathic drug on blood sugar
Time Frame: Every four week till 6 months
|
Blood Sugar measured in mmol/L every four week.
|
Every four week till 6 months
|
Effect of wheat grass, tulsi and allopathic drug on weight
Time Frame: Every four week till 6 months
|
Weight is measure in Kg every four week.
|
Every four week till 6 months
|
Effect of wheat grass, tulsi and allopathic drug on smoking
Time Frame: Every four week till 6 months
|
questionnaire assesment for "Smoking habits"
|
Every four week till 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 10, 2023
Primary Completion (Anticipated)
October 30, 2023
Study Completion (Anticipated)
October 30, 2023
Study Registration Dates
First Submitted
April 25, 2023
First Submitted That Met QC Criteria
May 5, 2023
First Posted (Actual)
May 9, 2023
Study Record Updates
Last Update Posted (Actual)
May 9, 2023
Last Update Submitted That Met QC Criteria
May 5, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- swalife001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
We will be sharing the Protocol of the study and the execution.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
Clinical Trials on Observation study
-
Charite University, Berlin, GermanyRecruiting
-
Taipei Veterans General Hospital, TaiwanUnknownGlycogen Storage Disease Type IITaiwan
-
Hospices Civils de LyonCompletedStudy of Practices of Surgeons on Surgical Management of Asymptomatic Hernias | Comparison With International RecommendationsFrance
-
Kyunghee University Medical CenterHangang Sacred Heart Hospital; Samsung Medical Center; Pusan National University... and other collaboratorsUnknown
-
The University of Hong KongActive, not recruitingChronic Low Back Pain | Chronic Neck PainHong Kong
-
Ottawa Hospital Research InstituteCompleted
-
Zhejiang UniversityRecruiting
-
SCM Lifescience Co., LTD.Active, not recruitingPancreatitis, AcuteKorea, Republic of
-
Shandong Provincial HospitalRecruitingBrain Aging Related ConditionsChina
-
Hampshire Hospitals NHS Foundation TrustRecruitingPeritoneal Cancer | Post-Splenectomy InfectionUnited Kingdom